Group One Trading’s Acura Pharmaceuticals ACUR Stock Holding History

Group One Trading’s Portfolio ACUR Stock Details ACUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-5,000	Closed	-$14K	–	5229
2016 Q1	$14K	Hold	5,000	–	–	﹤0.01%	3915
2015 Q4	$13K	Buy	+5,000	New	+$12.2K	﹤0.01%	4099
2014 Q3	–	Sell	-180	Closed	-$1K	–	5692
2014 Q2	$1K	Sell	180 -560	-76%	-$3.4K	﹤0.01%	5090
2014 Q1	$5K	Sell	740 -360	-33%	-$3.13K	﹤0.01%	4832
2013 Q4	$9K	Sell	1,100 -700	-39%	-$5.91K	﹤0.01%	4655
2013 Q3	$17K	Sell	1,800 -160	-8%	-$1.42K	﹤0.01%	4271
2013 Q2	$18K	Buy	+1,960	New	+$22.1K	﹤0.01%	4147

Other funds holding ACUR

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Group One Trading's ACUR Position: Q1 2017 in Review

Group One Trading sold out of Acura Pharmaceuticals (ACUR) in Q1 2017, closing a stake of 807 shares — an estimated $1K sold.

Group One Trading first reported a position in ACUR in Q2 2013 and held it in 13 quarters. The position peaked at $10K in Q3 2013. 3 funds tracked by Wall St. Rank hold ACUR as of Q1 2017.

Group One Trading reported no remaining Acura Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
Group One Trading sold 807 Acura Pharmaceuticals shares in Q1 2017, an estimated $1K.
Group One Trading first reported a position in Acura Pharmaceuticals in Q2 2013 and held it in 13 quarters.
Group One Trading's Acura Pharmaceuticals position peaked at $10K in Q3 2013.
3 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q1 2017.

Based on Group One Trading's 13F filing for Q1 2017, filed 10 May 2017.